Comparison Of In-Hospital Length Of Stay Between Patients Taking Rivaroxaban And Conventional Anticoagulants For Treatment Of Newly Diagnosed Venous Thromboembolism

被引:0
|
作者
Desai, A. K. [1 ]
Desai, A. R. [1 ]
Aparnath, M. [1 ]
Calixte, R. [1 ]
Hindenberg, A. [1 ]
Mathew, J. P. [1 ]
机构
[1] Winthrop Univ Hosp, Mineola, NY 11501 USA
关键词
PULMONARY-EMBOLISM; ORAL RIVAROXABAN;
D O I
暂无
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
A4871
引用
收藏
页数:2
相关论文
共 50 条
  • [31] Comparison of the Non-VKA Oral Anticoagulants Apixaban, Dabigatran, and Rivaroxaban in the Extended Treatment and Prevention of Venous Thromboembolism: Systematic Review and Network Meta-Analysis
    Cohen, A. T.
    Hamilton, M.
    Bird, A.
    Mitchell, S. A.
    Li, S.
    Horblyuk, R.
    Batson, S.
    PLOS ONE, 2016, 11 (08):
  • [32] Association between rivaroxaban use and length of hospital stay, treatment costs and early outcomes in patients with pulmonary embolism: a systematic review of real-world studies
    Kohn, Christine G.
    Fermann, Gregory J.
    Peacock, W. Frank
    Wells, Phil S.
    Baugh, Christopher W.
    Ashton, Veronica
    Crivera, Concetta
    Schein, Jeff R.
    Wildgoose, Peter
    Coleman, Craig I.
    CURRENT MEDICAL RESEARCH AND OPINION, 2017, 33 (09) : 1697 - 1703
  • [33] A Comparison of Supervised Machine Learning Techniques for Predicting Short-Term In-Hospital Length of Stay Among Diabetic Patients
    Mortona, April
    Marzban, Eman
    Giannoulis, Georgios
    Patel, Ayush
    Aparasu, Rajender
    Kakadiaris, Ioannis A.
    2014 13TH INTERNATIONAL CONFERENCE ON MACHINE LEARNING AND APPLICATIONS (ICMLA), 2014, : 428 - 431
  • [34] Oral Anticoagulant ( OAC) Use Among Medicare Patients Newly Diagnosed with Venous Thromboembolism (VTE): Factors Associated with Treatment Status
    Coons, James C.
    Wang, Aolin
    Latremouille-Viau, Dominick
    Russ, Cristina
    Cheng, Dong
    Stellhorn, Robert
    Dai, Feng
    Steffen, David R.
    Zion, Abigail
    Deeba, Serina
    Hines, Dionne M.
    BLOOD, 2023, 142
  • [35] Correlation between monocyte and length of in-hospital stay in patients with allergic rhinitis: data from the MIMIC-IV database
    Fang, Die
    Li, Jing
    Fang, Ping
    Ma, Zhi-qi
    Huang, Hui-ju
    Qian, Guo-ping
    Zhao, Jing
    Shi, Yan
    BMC ANESTHESIOLOGY, 2025, 25 (01):
  • [36] Association between length of stay, frequency of in-hospital death, and causes of death in Japanese patients with acute heart failure syndromes
    Kajimoto, Katsuya
    Sato, Naoki
    Keida, Takehiko
    Mizuno, Masayuki
    Sakata, Yasushi
    Asai, Kuniya
    Takano, Teruo
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 168 (01) : 554 - 556
  • [37] Multilevel factors associated with increased in-hospital length of stay among patients following head and neck cancer treatment.
    Boakye, Eric Adjei
    Tobo, Betelihem B.
    Chen, Jiajing
    Buchanan, Paula
    Malik, Shubhra
    Osazuwa-Peters, Nosayaba
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2018, 27 (07) : 69 - 69
  • [38] Do Differences in the Length of Hospital Stay Exist Between Patients Diagnosed With Pancreatic Cancer by Percutaneous, Endoscopic, or Surgical Biopsy?
    Mittal, Anmol
    Ahlawat, Sushil
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S30 - S31
  • [39] The association between inhaled long-acting bronchodilators and less in-hospital care in newly-diagnosed COPD patients
    Kim, Jinhee
    Kim, Kyungjoo
    Kim, Yuri
    Yoo, Kwang-Ha
    Lee, Chin Kook
    Yoon, Hyoung Kyu
    Kim, Young Sam
    Park, Young Bum
    Lee, Jin Hwa
    Oh, Yeon-Mok
    Lee, Sang-Do
    Lee, Sei Won
    RESPIRATORY MEDICINE, 2014, 108 (01) : 153 - 161
  • [40] THE IMPACT OF TIME-DEPENDENT BIAS ON EVALUATION OF INPATIENT COST AND LENGTH OF STAY IN HOSPITAL-ASSOCIATED VENOUS THROMBOEMBOLISM AMONG ARTHROPLASTY PATIENTS
    Ma, J.
    Nelson, R. E.
    Brixner, D., I
    Witt, D. M.
    Bress, A. P.
    LaFleur, J.
    VALUE IN HEALTH, 2019, 22 : S373 - S373